Ariana is pleased to announce that Professor Jacques Touchon, a world renown neurologist, Alzheimer’s Disease specialist and co-founder of the Clinical Trials on Alzheimer’s Disease (CTAD) international convention has joined its scientific advisory board.

Professor Touchon will help bolster Ariana Pharma’s clinical expertise in the field of CNS diseases and expand the company’s collaborations internationally. He will be joining on Ariana’s SAB Professor Jean Sallantin, a pioneer of French bioinformatics and former Director of the Artificial Intelligence Laboratories at the LIRMM CNRS and Dr Alain Commerçon, former Senior Research Director within the Lead Generation organization at Sanofi-Aventis.

Professor Touchon received his Medical Degree in 1979 and his specialty in Neurology in 1992 from the Medical School of Montpellier. He has been a Professor of Neurology at the Medical School University since 1990 and Dean of the School of Medicine (2000-10). In 2004, he was appointed Chief of Neurology at Montpellier University Research Hospital and was the director of the Center for Memory Resources and Research for the Languedoc-Roussillon region. In 1999 he was awarded the academic palms for his research on Alzheimer’s Disease and the Pinel Prize and was also the recipient of the Légion d’Honneur in 2007. He is currently the Editor in chief of the Journal of Prevention of Alzheimer’s Disease (JPAD).